Investigational Site Number 1008011

Gabrovo 5300

0 studies enrolling now · 1 studies all time

What they study most

Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin — Completed